Kidney/Renal Disease
Show Only Open Trials
1.
Relationship of Plasma Renin Activity to Response of Microalbuminuria to Angiotensin Converting Enzyme Inhibition
- Study Status: Open to Enrollment
- Sponsor: Hypertension Research Fund
2.
Using mTOR Inhibitors in the Prevention of BK Nephropathy
- Study Status: Open to Enrollment
- Sponsor: Pfizer, Columbia University
3.
BMS CA204007: A Phase 1b Study of Elotuzumab in Combination with Lenalidomide and Dexamethasone in Subjects with Multiple Myeloma and Normal Renal Function, Severe Renal Impairment, or End Stage Renal Disease Requiring Dialysis
- Study Status: Open to Enrollment
- Sponsor: Bristol-Myers Squibb
- Disease Status and/or Stage: Multiple Multiple and Normal Renal Function, Severe Renal Impairment, or on Dialysis
- Protocol ID: BMS CA204007
4.
Characterization of Intestinal Microbiota to Evaluate Kidney Allograft Status
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Clinical and Translational Science Center
5.
RESTARRT: Immunosuppression with Anti-thymocyte Globuline, Rituximab, Tacrolimus, and Sirolimus, Followed by Withdrawal of Tacrolimus and Sirolimus, in Living-donor Renal Transplant Recipients
- Study Status: Open to Enrollment
- Sponsor: NIAID; Immune Tolerance Network (ITN)
- Disease Status and/or Stage: Renal Transplant Recipients
6.
Use of PCR to Evaluate Renal Allograft Status (Diagnostic and Serial Biopsies)
- Study Status: Open to Enrollment
- Sponsor: NIH; Qatar National Research Foundation (QNRF); Quest Diagnostics, Inc.
7.
Evaluation of Subclinical Renal Allograft Damage
- Study Status: Open to Enrollment
- Sponsor: NIAID/NIH; Qatar National Research Foundation (QNRF)
8.
Cytokine Levels in Hypertensive and Normotensive Individuals
- Study Status: Closed to Enrollment